Deaths among women with lung cancer are predicted to increase by almost half before 2030, as the harmful legacy of tobacco firms’ targeting female smokers in the 20th century continues to unfold.
Among women with the disease across 52 countries the average mortality rate is due to increase by 43 per cent between 2015 and 2030, according to research published in the journal Cancer Research on Wednesday.
Oncimmune (LON:ONC) is a leading early cancer detection company. It has pioneered the development of autoantibody assay technologies that have the potential to allow cancer detection up to four years earlier than other methods and can be applied to a wide range of solid tumour types.
